Posted
16th June 2025
Products
This World Continence Week, Clinell Contiplan 3-in-1 Cream Cloths introduce expanded clinical indications and structured care pathways to support consistent, evidence-based continence care. Incontinence-associated dermatitis (IAD) remains a prevalent and challenging complication in both acute and aged care settings, impacting comfort, increasing infection risks, and placing additional demands on care teams.¹˒²
Clinell Contiplan 3-in-1 Expanded Indications
Clinell Contiplan 3-in-1 Cream Cloths offer a simplified, evidence-based solution for the prevention and management of incontinence-associated dermatitis (IAD). Designed to cleanse, moisturise, and protect in one single step, they eliminate the need for multiple products, helping streamline clinical routines. Powered by Advanced Barrier Protection (ABP™) Technology, each cloth delivers multi-layered defence through:
- Humectants
- Emollients
- Protective lipids
- Occlusive barrier

Each cream-infused cloth ensures consistent application for optimal hydration and barrier protection. The pH-balanced, gentle formulation makes Clinell Contiplan 3-in-1 Cream Cloths suitable for use on intact, broken, or damaged skin across all age groups, including neonates*.
Continence Care Pathways
Clinell Contiplan continence care pathways are structured, evidence-based frameworks that guide healthcare providers in delivering consistent, high-quality care to patients experiencing IAD. As visual tools, these pathways are tailored to meet facility-specific needs and clearly define when and how to use Clinell Contiplan 3-in-1 Cream Cloths, leading to:
- Enhanced compliance & consistency: Standardised care improves adherence to best practices.
- Improved outcomes: Supports skin integrity and prevents IAD-related complications.
- Reduced misuse: Clear guidelines reduce the risk of product misapplication.

Proven Outcomes in Continence Care
Case Study 1: Sanctuary Care – Improved Skin Integrity in Elderly Residents3
An observational study in a UK long-term care setting assessed the impact of Clinell Contiplan 3-in-1 Cream Cloths on skin integrity and care efficiency among residents with IAD. The findings demonstrated:
- 55% improvement in skin integrity within five days, with skin assessment scores decreasing from 110 to 50, demonstrating effective IAD management. Skin assessment scoring tool was a GAMA scoring tool, created in conjunction with Sanctuary Care.
- Care episodes significantly shortened, with time reduced from 16.4 to 5.8 minutes, representing a 65% reduction in time required per procedure.
- Reduction in product usage, with the number of wipes per episode dropping from six to two and total product use falling from four to one, leading to 40% cost savings and improved sustainability.

Case Study 2: East Suffolk and North Essex NHS Foundation Trust – Reduction in IAD Prevalence4
A quasi-experimental observational study conducted in a UK hospital assessed the effectiveness of Clinell Contiplan 3-in-1 Cream Cloths in reducing hospital-acquired IAD rates and improving workflow efficiency.
Key findings included:
- 31% reduction in IAD incidence, with cases decreasing from 8.7 to 6 per month across five wards.
- More than 60% reduction in care time, with incontinence care time decreasing from 17.76 minutes pre-intervention to 6.4 minutes post-intervention.
- Substantial improvement in patient comfort:
- Pre-intervention: 46% of patients reported comfort, 37% experienced discomfort, and 17% reported pain or slight pain.
- Post-intervention: 96% of patients reported comfort, with only 4% experiencing discomfort.
Additionally, 100% of staff surveyed found the wipes to be patient-friendly, easy to use, and preferred over traditional cleansing methods.

Case Study 3: Western Australia – Managing Chronic IAD in a High-Risk Patient5
An 81-year-old female patient with multiple comorbidities and sensitivities to wound care products had a Stage 2 IAD-related pressure injury that persisted for 1260 days. Despite conventional treatments, the condition remained unresolved.
Following the introduction of Clinell Contiplan 3-in-1 Cream Cloths as part of a comprehensive skin care regimen, which included removal of the indwelling catheter and regular toileting, results showed:
- Complete wound closure within 73 days, demonstrating effective skin barrier restoration.
- Marked improvement in quality of life, with increased social engagement, participation in activities, and communal dining.
- Operational efficiency gains, as caregivers reported simplified skin care procedures with the single-step intervention.

Clinical Implications and Future Considerations
The findings from these case studies reinforce the clinical efficacy of Clinell Contiplan 3-in-1 Cream Cloths, particularly in complex care environments. The demonstrated reduction in IAD prevalence, enhanced patient comfort, and streamlined caregiver workflows highlight their role as a valuable intervention in both acute and long-term care settings. These clinical findings demonstrate significant improvements in skin integrity, patient comfort, and care efficiency, and enhanced workflow in various healthcare settings.
References:
- McNichol L, Bliss DZ, Gray M. Moisture-associated skin damage. J Wound Ostomy Continence Nurs. 2022;49(3):235-239.
- Beeckman D, Campbell J, Campbell K, et al. Proceedings of the Global IAD Expert Panel: Incontinence-associated dermatitis—moving prevention forward. Wounds International. 2015.
- Chitura M, Wares KD, Saviolaki G. Nurturing skin health through simplified incontinence-associated dermatitis (IAD) care. Presented at: European Wound Management Association (EWMA) Conference; February 21, 2024; London, UK.
- Knight A, Wares KD. Improving incontinence-associated dermatitis (IAD) rates in a hospital setting by simplifying care. Poster presented at: European Wound Management Association (EWMA) Conference; March 2025; Barcelona, Spain.
- Clarke R, Wares KD, Saviolaki G. 3-in-1 continence care cloth intervention for managing incontinence-associated dermatitis in a geriatric patient: A case study. Presented at: Wounds Australia Conference; October 2024; Australia.
* As with application of any liquid to the baby’s skin, tissue viability should be considered for extreme or very low birth weight babies.
SHARE THIS ARTICLE
Tags
Latest News
Advancing Continence Care with Clinell Contiplan: Expanded Indications, Pathways and Proven Outcomes
This World Continence Week, Clinell Contiplan 3-in-1 Cream Cloths introduce…
Celebrating 20 Years of GAMA Healthcare: Our Story
This month, GAMA Healthcare celebrates 20 years of helping prevent…
Norovirus and gastroenteritis outbreaks, the party ‘pooper’ you don’t want invited!
Recently, on 11 October 2024, NSW Health issued a health…
Clean Between to Reduce Healthcare-Associated Infections
Healthcare-associated infections (HAIs) are a significant concern for healthcare facilities…